关注
Niloofar Farboodi
Niloofar Farboodi
在 usc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Effect of access to prescribed PCSK9 inhibitors on cardiovascular outcomes
KD Myers, N Farboodi, M Mwamburi, W Howard, D Staszak, S Gidding, ...
Circulation: Cardiovascular Quality and Outcomes 12 (8), e005404, 2019
702019
A clinic‐based screening of mutations in exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's disease patients
S Shojaee, F Sina, N Farboodi, Z Fazlali, F Ghazavi, SA Ghorashi, ...
Movement Disorders 24 (7), 1023-1027, 2009
312009
Clinical spectrum in multiple families with primary COQ10 deficiency
SS Hashemi, D Zare‐Abdollahi, MK Bakhshandeh, A Vafaee, ...
American Journal of Medical Genetics Part A 185 (2), 440-452, 2021
222021
The second family affected with a PRDM8-related disease
A Davarzani, A Shahrokhi, SS Hashemi, A Ghasemi, ...
Neurological Sciences, 1-9, 2022
82022
A case of adult onset Sandhoff disease that mimics Brown-Vialetto-Van Laere syndrome
M Khani, H Shamshiri, H Moazzeni, H Taheri, H Ahmadieh, A Alavi, ...
Neuromuscular Disorders 31 (6), 528-531, 2021
12021
Identification of DHR96 Target Genes
N Farboodi
University of Alberta, 2011
2011
系统目前无法执行此操作,请稍后再试。
文章 1–6